Frequent detection of genetic aberrations reveals novel pathogenesis and treatment modalities in systemic juvenile xanthogranuloma
- PMID: 37736360
- PMCID: PMC10509386
- DOI: 10.1002/ped4.12398
Frequent detection of genetic aberrations reveals novel pathogenesis and treatment modalities in systemic juvenile xanthogranuloma
Conflict of interest statement
None.
Similar articles
-
Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity.Mod Pathol. 2017 Sep;30(9):1234-1240. doi: 10.1038/modpathol.2017.50. Epub 2017 Jul 28. Mod Pathol. 2017. PMID: 28752840
-
Risk of intraocular and other extracutaneous involvement in patients with cutaneous juvenile xanthogranuloma.Pediatr Dermatol. 2018 May;35(3):329-335. doi: 10.1111/pde.13437. Epub 2018 Feb 28. Pediatr Dermatol. 2018. PMID: 29488239 Review.
-
Multiple juvenile xanthogranuloma.Dermatol Online J. 2024 Mar 15;30(1). doi: 10.5070/D330163291. Dermatol Online J. 2024. PMID: 38762861
-
Neonatal systemic juvenile Xanthogranuloma with Hydrops diagnosed by Purpura skin biopsy: a case report and literature review.BMC Pediatr. 2021 Apr 6;21(1):161. doi: 10.1186/s12887-021-02632-0. BMC Pediatr. 2021. PMID: 33823829 Free PMC article. Review.
-
Juvenile xanthogranuloma with lichenoid appearance.J Dermatol. 2012 May;39(5):462-5. doi: 10.1111/j.1346-8138.2011.01394.x. Epub 2011 Oct 10. J Dermatol. 2012. PMID: 21980990
Cited by
-
Pediatric Necrobiotic Xanthogranuloma as a Novel Phenotype of IKAROS Gain of Function.J Clin Immunol. 2023 Dec 22;44(1):19. doi: 10.1007/s10875-023-01622-4. J Clin Immunol. 2023. PMID: 38129715 Free PMC article. No abstract available.
References
-
- Diamond EL, Durham BH, Haroche J, Yao Z, Ma J, Parikh SA, et al. Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov. 2016;6:154‐165. DOI:10.1158/2159-8290.CD-15-0913 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources